Wealth Enhancement Advisory Services LLC Acquires 9,296 Shares of Humana Inc. (NYSE:HUM)

Wealth Enhancement Advisory Services LLC increased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 144.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,734 shares of the insurance provider's stock after acquiring an additional 9,296 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Humana were worth $4,163,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. Retirement Planning Co of New England Inc. boosted its stake in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock worth $245,000 after acquiring an additional 43 shares in the last quarter. LFA Lugano Financial Advisors SA lifted its stake in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after buying an additional 45 shares in the last quarter. First Horizon Advisors Inc. lifted its stake in shares of Humana by 11.5% in the fourth quarter. First Horizon Advisors Inc. now owns 581 shares of the insurance provider's stock worth $148,000 after buying an additional 60 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its stake in shares of Humana by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,316 shares of the insurance provider's stock worth $2,617,000 after buying an additional 62 shares in the last quarter. Finally, Vise Technologies Inc. lifted its stake in shares of Humana by 8.0% in the fourth quarter. Vise Technologies Inc. now owns 873 shares of the insurance provider's stock worth $221,000 after buying an additional 65 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Stock Up 0.7%

HUM opened at $240.24 on Friday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The company has a market capitalization of $28.99 billion, a PE ratio of 16.99, a PEG ratio of 1.80 and a beta of 0.43. The firm's 50 day simple moving average is $242.39 and its two-hundred day simple moving average is $259.73.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. During the same period last year, the firm earned $7.23 earnings per share. The company's quarterly revenue was up 8.4% on a year-over-year basis. As a group, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.47%. Humana's payout ratio is presently 25.04%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on HUM. Bank of America dropped their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research note on Tuesday, June 17th. Guggenheim began coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a "buy" rating and a $326.00 target price on the stock. Truist Financial set a $280.00 target price on shares of Humana and gave the stock a "hold" rating in a research note on Tuesday, June 17th. Mizuho upped their target price on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Finally, Barclays set a $268.00 target price on shares of Humana and gave the stock an "equal weight" rating in a research note on Thursday, June 12th. Seventeen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, Humana presently has a consensus rating of "Hold" and a consensus price target of $280.76.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.